Shirokov, D.; Lepekhina, D.; Manuvera, V.; Bogomiakova, M.; Strokach, A.; Kazakova, A.; Arapidi, G.; Lazarev, V.
Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability. Int. J. Mol. Sci. 2025, 26, 12016.
https://doi.org/10.3390/ijms262412016
AMA Style
Shirokov D, Lepekhina D, Manuvera V, Bogomiakova M, Strokach A, Kazakova A, Arapidi G, Lazarev V.
Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability. International Journal of Molecular Sciences. 2025; 26(24):12016.
https://doi.org/10.3390/ijms262412016
Chicago/Turabian Style
Shirokov, Dmitriy, Daria Lepekhina, Valentin Manuvera, Margarita Bogomiakova, Aleksandra Strokach, Anastasia Kazakova, Georgij Arapidi, and Vassili Lazarev.
2025. "Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability" International Journal of Molecular Sciences 26, no. 24: 12016.
https://doi.org/10.3390/ijms262412016
APA Style
Shirokov, D., Lepekhina, D., Manuvera, V., Bogomiakova, M., Strokach, A., Kazakova, A., Arapidi, G., & Lazarev, V.
(2025). Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability. International Journal of Molecular Sciences, 26(24), 12016.
https://doi.org/10.3390/ijms262412016